EUCTR2011-002362-21-IT进行中（未招募）不适用
A randomised, double-blind, parallel-group, active-controlled, flexible dose study evaluating the effects of Lu AA21004 versus agomelatine in adult patients suffering from major depressive disorder with inadequate response to antidepressant treatment
H.LUNDBECK A/S0 个研究点目标入组 500 人开始时间: 2012年3月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The patient is a man or woman, between 18 and 75 years old (inclusive) • The patient is being treated with an SRI antidepressant (monotherapy) that was prescribed to treat Major Depressive Episode (DSM-IV-TR criteria) • The response to the current SRI treatment is inadequate and patient agrees to discontinue the current SRI at the baseline • MADRS total score =22 at the Screening Visit and Baseline • The patient, if a woman, must: agree not to try to become pregnant during the study, AND use adequate, highly effective contraception • Other protocol-defined inclusion criteria may apply
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 395
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 105
排除标准
- •The patient has any current Axis I disorders (DSM-IV criteria) other
- •than MDD, GAD and SAD
- •The patient is at significant risk of suicide
- •The patient is currently receiving formal psychotherapy or
- •otherpsychoactive medications
- •Other protocol-defined exclusion criteria may apply
研究者
相似试验
进行中（未招募）
1 期
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression ( VIVRE )EUCTR2019-002704-41-ESH. Lundbeck A/S600
进行中（未招募）
1 期
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression ( VIVRE )EUCTR2019-002704-41-CZH. Lundbeck A/S600
进行中（未招募）
不适用
A study of the new pharmaceutical LuAA21004 in comparison to agomelatine in adults suffering from major depression who did not respond well to previous medication.EUCTR2011-002362-21-ESH. Lundbeck A/S500
进行中（未招募）
1 期
A study of the new pharmaceutical LuAA21004 in comparison to agomelatine in adults suffering from major depression who did not respond well to previous medication.-Major Depressive Disorder (MDD)MedDRA version: 14.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-002362-21-BEH. Lundbeck A/S500
进行中（未招募）
不适用
A study of the new pharmaceutical LuAA21004 in comparison to agomelatine in adults suffering from major depression who did not respond well to previous medication.-Major Depressive Disorder (MDD)MedDRA version: 14.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-002362-21-EEH. Lundbeck A/S500